Department of Pharmaceutical Chemistry, School of Pharmaceutical & Populations Health Informatics, DIT University, Dehradun, 248009, India.
Department of Pharmaceutical Chemistry, Bhupal Nobles' College of Pharmacy, Bhupal Nobles' University, Udaipur, 313001, India.
Mol Divers. 2023 Aug;27(4):1689-1701. doi: 10.1007/s11030-022-10522-5. Epub 2022 Sep 5.
Despite the various research efforts towards the drug discovery program for Zika virus treatment, no antiviral drugs or vaccines have yet been discovered. The spread of the mosquito vector and ZIKV infection exposure is expected to accelerate globally due to continuing global travel. The NS3-Hel is a non-structural protein part and involved in different functions such as polyprotein processing, genome replication, etc. It makes an NS3-Hel protein an attractive target for designing novel drugs for ZIKV treatment. This investigation identifies the novel, potent ZIKV inhibitors by virtual screening and elucidates the binding pattern using molecular docking and molecular dynamics simulation studies. The molecular dynamics simulation results indicate dynamic stability between protein and ligand complexes, and the structures keep significantly unchanged at the binding site during the simulation period. All inhibitors found within the acceptable range having drug-likeness properties. The synthetic feasibility score suggests that all screened inhibitors can be easily synthesizable. Therefore, possible inhibitors obtained from this study can be considered a potential inhibitor for NS3 Hel, and further, it could be provided as a lead for drug development.
尽管在针对寨卡病毒治疗的药物发现计划方面进行了各种研究努力,但尚未发现抗病毒药物或疫苗。由于持续的全球旅行,蚊子传播媒介和寨卡病毒感染暴露预计将在全球范围内加速。NS3-Hel 是一种非结构蛋白部分,参与多种功能,如多蛋白加工、基因组复制等。这使得 NS3-Hel 蛋白成为设计用于寨卡病毒治疗的新型药物的有吸引力的靶标。这项研究通过虚拟筛选鉴定了新型、有效的寨卡病毒抑制剂,并通过分子对接和分子动力学模拟研究阐明了结合模式。分子动力学模拟结果表明,蛋白质和配体复合物之间具有动态稳定性,并且在模拟期间结构在结合部位保持显著不变。在可接受范围内发现的所有抑制剂均具有类药性。合成可行性评分表明,所有筛选出的抑制剂都易于合成。因此,从这项研究中获得的可能抑制剂可以被认为是 NS3 Hel 的潜在抑制剂,并且可以进一步作为药物开发的先导物提供。